Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Abdullah M Alshehri

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
World Journal of Critical Care Medicine|June 10, 2025
Driving pressure in acute respiratory distress syndrome for developing a protective lung strategy: A systematic reviewHassan A Alzahrani, Nadia Corcione, Saeed M Alghamdi, et al.
Heart & Lung : the Journal of Critical Care|May 5, 2020
Patient-Ventilator Asynchrony in Critical Care Settings: National Outcomes of Ventilator Waveform AnalysisJaber S Alqahtani, Mohammed D AlAhmari, Khalid H Alshamrani, et al.
Drug Metabolism and Personalized Therapy|April 6, 2022
Prevalence of <i>CYP2C19*2</i> carriers in Saudi ischemic stroke patients and the suitability of using genotyping to guide antiplatelet therapy in a university hospital setupAbdullah M Al-Rubaish, Fahad A Al-Muhanna, Abdullah M Alshehri, et al.
Cureus|December 21, 2022
The Overriding of Computerized Physician Order Entry (CPOE) Drug Safety Alerts Fired by the Clinical Decision Support (CDS) Tool: Evaluation of Appropriate Responses and Alert Fatigue SolutionsAnjum Naeem, Ali F Alwadie, Abdullah M Alshehri, et al.
Drug Metabolism and Personalized Therapy|July 8, 2021
Prevalence of <i>CYP2C19*2</i> carriers in Saudi ischemic stroke patients and the suitability of using genotyping to guide antiplatelet therapy in a university hospital setupAbdullah M Al-Rubaish, Fahad A Al-Muhanna, Abdullah M Alshehri, et al.
Cureus|October 2, 2024
Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists: Exploring Their Impact on Diabetes, Obesity, and Cardiovascular Health Through a Comprehensive Literature ReviewKhalid Hamed, Mohammed N Alosaimi, Bashaer A Ali, et al.
Pharmaceuticals (Basel, Switzerland)|June 27, 2024
Activation of AMPK/mTOR-Driven Autophagy and Suppression of the HMGB1/TLR4 Pathway with Pentoxifylline Attenuates Doxorubicin-Induced Hepatic Injury in RatsHany H Arab, Ahmed H Eid, Shuruq E Alsufyani, et al.
Scientific Reports|December 10, 2023
Uncovering myocardial infarction genetic signatures using GWAS exploration in Saudi and European cohortsAmein K Al-Ali, Abdullah M Al-Rubaish, Rudaynah A Alali, et al.
International Journal of Cardiology|September 10, 2021
Bedside testing of CYP2C19 vs. conventional clopidogrel treatment to guide antiplatelet therapy in ST-segment elevation myocardial infarction patientsAbdullah M Al-Rubaish, Fahad A Al-Muhanna, Abdullah M Alshehri, et al.
BMC Cardiovascular Disorders|June 5, 2020
Bedside testing of CYP2C19 gene for treatment of patients with PCI with antiplatelet therapyAbdullah M Al-Rubaish, Fahad A Al-Muhanna, Abdullah M Alshehri, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
World Journal of Critical Care Medicine|June 10, 2025
Driving pressure in acute respiratory distress syndrome for developing a protective lung strategy: A systematic reviewHassan A Alzahrani, Nadia Corcione, Saeed M Alghamdi, et al.
Heart & Lung : the Journal of Critical Care|May 5, 2020
Patient-Ventilator Asynchrony in Critical Care Settings: National Outcomes of Ventilator Waveform AnalysisJaber S Alqahtani, Mohammed D AlAhmari, Khalid H Alshamrani, et al.
Drug Metabolism and Personalized Therapy|April 6, 2022
Prevalence of <i>CYP2C19*2</i> carriers in Saudi ischemic stroke patients and the suitability of using genotyping to guide antiplatelet therapy in a university hospital setupAbdullah M Al-Rubaish, Fahad A Al-Muhanna, Abdullah M Alshehri, et al.
Cureus|December 21, 2022
The Overriding of Computerized Physician Order Entry (CPOE) Drug Safety Alerts Fired by the Clinical Decision Support (CDS) Tool: Evaluation of Appropriate Responses and Alert Fatigue SolutionsAnjum Naeem, Ali F Alwadie, Abdullah M Alshehri, et al.
Drug Metabolism and Personalized Therapy|July 8, 2021
Prevalence of <i>CYP2C19*2</i> carriers in Saudi ischemic stroke patients and the suitability of using genotyping to guide antiplatelet therapy in a university hospital setupAbdullah M Al-Rubaish, Fahad A Al-Muhanna, Abdullah M Alshehri, et al.
Cureus|October 2, 2024
Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists: Exploring Their Impact on Diabetes, Obesity, and Cardiovascular Health Through a Comprehensive Literature ReviewKhalid Hamed, Mohammed N Alosaimi, Bashaer A Ali, et al.
Pharmaceuticals (Basel, Switzerland)|June 27, 2024
Activation of AMPK/mTOR-Driven Autophagy and Suppression of the HMGB1/TLR4 Pathway with Pentoxifylline Attenuates Doxorubicin-Induced Hepatic Injury in RatsHany H Arab, Ahmed H Eid, Shuruq E Alsufyani, et al.
Scientific Reports|December 10, 2023
Uncovering myocardial infarction genetic signatures using GWAS exploration in Saudi and European cohortsAmein K Al-Ali, Abdullah M Al-Rubaish, Rudaynah A Alali, et al.
International Journal of Cardiology|September 10, 2021
Bedside testing of CYP2C19 vs. conventional clopidogrel treatment to guide antiplatelet therapy in ST-segment elevation myocardial infarction patientsAbdullah M Al-Rubaish, Fahad A Al-Muhanna, Abdullah M Alshehri, et al.
BMC Cardiovascular Disorders|June 5, 2020
Bedside testing of CYP2C19 gene for treatment of patients with PCI with antiplatelet therapyAbdullah M Al-Rubaish, Fahad A Al-Muhanna, Abdullah M Alshehri, et al.
Pageof 4